QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 17, Issue 1, 213-226, January 2006

This Article Abstract Full Text (PDF) Supplemental Material All Versions of this Article: E05-06-0585v1 17/1/213    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dunn, C. D. Articles by Jensen, R. E. Search for Related Content PubMed PubMed Citation Articles by Dunn, C. D. Articles by Jensen, R. E.

A Genomewide Screen for Petite-negative Yeast Strains Yields a New Subunit of the i-AAA Protease Complex

Cory D. Dunn ^*, Marina S. Lee  , Forrest A. Spencer , and Robert E. Jensen ^*

^* Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205; Departments of McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205

Submitted June 30, 2005; Revised October 19, 2005; Accepted October 21, 2005
Monitoring Editor: Thomas Fox

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
Unlike many other organisms, the yeast Saccharomyces cerevisiae can tolerate the loss of mitochondrial DNA (mtDNA). Although a few proteins have been identified that are required for yeast cell viability without mtDNA, the mechanism of mtDNA-independent growth is not completely understood. To probe the relationship between the mitochondrial genome and cell viability, we conducted a microarray-based, genomewide screen for mitochondrial DNA-dependent yeast mutants. Among the several genes that we discovered is MGR1, which encodes a novel subunit of the i-AAA protease complex located in the mitochondrial inner membrane. mgr1 mutants retain some i-AAA protease activity, yet mitochondria lacking Mgr1p contain a misassembled i-AAA protease and are defective for turnover of mitochondrial inner membrane proteins. Our results highlight the importance of the i-AAA complex and proteolysis at the inner membrane in cells lacking mitochondrial DNA.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
Mitochondria are found in virtually all eukaryotic cells, playing key roles in diverse processes such as ATP synthesis, ion homeostasis, lipid metabolism, cell fate determination, apoptosis, and aging (Tzagoloff et al., 1994; Green and Kroemer, 2004; Trifunovic et al., 2004). The 1000 proteins that make up a mitochondrion (Mootha et al., 2003; Sickmann et al., 2003; Jensen et al., 2004) are encoded either in the nucleus or by mitochondrial DNA (mtDNA). The vast majority of these proteins are encoded in the nuclear genome, synthesized in the cytosol, and then imported into one of four mitochondrial locations: the outer membrane (OM), the intermembrane space (IMS), the inner membrane (IM) or the matrix (Rehling et al., 2004). mtDNA encodes only a small number of proteins, most of which are subunits of the large, inner membrane complexes that mediate oxidative phosphorylation (Attardi and Schatz, 1988).

The yeast S. cerevisiae can grow in the absence of mtDNA. Yeast strains that contain wild-type mtDNA, or "rho⁺" cells, are able to respire and can grow on nonfermentable media (Tzagoloff, 1982). Cells that contain nonfunctional, mutated mtDNA (rho^–) or have completely lost their mtDNA (rho⁰) are called "cytoplasmic petite" mutants. Because rho⁰ cells lack a mitochondrial genome, they lack functional mtDNA-encoded subunits of both the electron transport chain and the ATP synthase, and they grow only by glycolysis on fermentable carbon sources such as glucose (Tzagoloff, 1982). The inner membrane electrochemical potential ()is required for mitochondrial ATP synthesis, for the transport of many small molecules into and out of the matrix (Tzagoloff, 1982), and for the import of proteins from the cytosol (Rehling et al., 2004). In yeast cells with intact mtDNA, the IM potential is largely produced by the electron transport chain, which pumps protons across the IM to the IMS (Tzagoloff, 1982). However, in cells without mtDNA, appears to be maintained by electrogenic exchange of ATP^–4 generated by glycolysis for ADP^–3 produced by the F₁-ATPase (Dupont et al., 1985; Giraud and Velours, 1997). This model comes from the observations that yeast mutants lacking the major ATP/ADP carrier (Kovacova et al., 1968) or cells without functional F₁-ATPase (Ebner and Schatz, 1973; Chen and Clark-Walker, 1999) cannot live without their mtDNA, even when they are grown on glucose-containing medium. These mtDNA-dependent yeast cells are called "petite-negative" mutants (Chen and Clark-Walker, 2000).

Defects in several other proteins cause a petite-negative phenotype. For example, we reported that yeast lacking the mitochondrial protein import components Tim18p and Tom70p do not grow without functional mtDNA (Kerscher et al., 2000; Dunn and Jensen, 2003). Others have demonstrated that yeast mutated for import components Tim9p, Tim10p, and Tim12p are unable to live without mtDNA (Senapin et al., 2003). However, the relationship between these different import components and mtDNA requirement remains unclear. Yeast mutants deficient in Yme1p, an ATP- and zinc-dependent protease located in the IM (Nakai et al., 1995; Leonhard et al., 1996; Weber et al., 1996), also exhibit a severe growth defect on glucose medium in the absence of mtDNA (Thorsness et al., 1993). Yme1p is found in a large structure in the IM, called the "i-AAA protease complex," which may play an important role in the F₁-ATPase activity of rho⁰ cells (Weber et al., 1995; Kominsky et al., 2002). To further understand the requirement for the mitochondrial genome in yeast, we conducted a genomewide, microarray-based screen for petite-negative mutants. Although some of the mutants that we identified have previously been described as petite-negative, several other mutants are components of cellular pathways that were not known to be required for the viability of yeast lacking mtDNA. One mutant from our screen is defective in an uncharacterized protein, which we have named Mgr1p. Mgr1p is located in the mitochondrial IM, interacts with Yme1p, and is a new subunit of the i-AAA protease complex.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
Strains, Media, and Genetic Methods
A list of the strains used in this study and their genotypes are located in Supplementary Table 1. Diploid strain RJ605 was generated by crossing FY833 (Winston et al., 1995) to FY844 (Winston et al., 1995). Strain RJ1970, which expresses an Mgr1p-myc fusion protein, was constructed by homologous recombination in diploid strain RJ605 using the MYC::TRP1 cassette from pFA6a-13Myc-TRP1 (Longtine et al., 1998) amplified by oligonucleotides 1620 and 1621 (see Supplementary Table 2). After sporulation, haploid strains RJ1970 (MGR1-MYC) and RJ1971 (MGR1) were isolated. Strain RJ1688 was made by transforming mgr1 strain RJ2058 with plasmid pM486 expressing MGR1-GFP. mgr1 strain RJ1961 was generated by gene replacement using the TRP1 gene from plasmid pRS304 (Sikorski and Hieter, 1989), the diploid strain RJ605, and oligonucleotides 1652 and 1653. After sporulation, mgr1 strain RJ1961 and MGR1 strain RJ1962 were isolated. MGR1-MYC yme1 strain RJ1972 and yme1 strain RJ1974 were constructed using the URA3 gene from plasmid pRS306 (Sikorski and Hieter, 1989), primers 834 and 835, and MGR1-MYC strain RJ1970 or MGR1 strain RJ1971. MGR1-MYC YME1-HA strain RJ1980 was constructed by homologous recombination in MGR1-MYC strain RJ1970 using the HA::kanMX6 cassette from pFA6a-3HA-kanMX6 (Longtine et al., 1998) amplified by oligonucleotides 1662 and 1663. mgr1 strains RJ2001 and RJ2059 were constructed using the kanMX4 marker from pRS400 (Brachmann et al., 1998), primers 1652 and 1653, and strain PTY44 (Thorsness and Fox, 1993) or strain BY4742 (Brachmann et al., 1998). Similarly, yme1 strains RJ2040 and RJ2051 were made using oligonucleotides 834 and 835, and strains PTY44 or BY4742. NDE1-HA strain RJ2077, mgr1 NDE1-HA strain RJ2078, and yme1 NDE1-HA strain RJ2079 were generated with the HA::kanMX6 cassette from pFA6a-3HA-kanMX6 (Longtine et al., 1998), oligonucleotides 1823 and 1824, and either mgr1 strain RJ1961, yme1 strain RJ1974, or wild-type strain RJ1962. mrpl16 strains RJ1924 and RJ1925 were made using diploid strain RJ1082 (Kerscher et al., 2000), the LEU2 gene from pRS305 (Sikorski and Hieter, 1989), and primers 1559 and 1560. After sporulation, haploid mrpl16 strains RJ1924 and RJ1925 were isolated. yta10/YTA10 yta12/YTA12 yme1/YME1 strain RJ2056 was constructed by disrupting YTA10, using primers 836 and 837 and the HIS3 gene from plasmid pRS303 (Sikorski and Hieter, 1989), YME1, using primers 834 and 835 and the kanMX4 gene from pRS400 and YTA12, using primers 1784 and 1785 and the TRP1 gene from pRS304 (Sikorski and Hieter, 1989), in diploid strain RJ605. Media and genetic techniques were as described (Adams et al., 1997).

Microarray Screen for Petite-negative Deletion Mutants
A pool of cells representing 3800 haploid yeast knockout mutants (Ooi et al., 2001) was diluted to an OD₆₀₀ of 2 x 10^–3 into 100 ml of YEPD media, or 100 ml of YEPD containing 25 µg/ml ethidium bromide (EtBr; Sigma, St. Louis, MO). Cultures of EtBr-treated and untreated cells were grown for 18 generations at 30°C, and then 10 OD₆₀₀ units of cells from each culture were harvested by centrifugation. After genomic DNA isolation (Adams et al., 1997), probes corresponding to the DOWNTAG, a distinct 20-bp DNA sequence that uniquely identifies each YKO mutant (Shoemaker et al., 1996; Winzeler et al., 1999; Giaever et al., 2002), were prepared by PCR amplification using oligonucleotides D1 and D2 labeled with either the Cy3 or Cy5 fluorophore. In three experiments, Cy5-labeled primers were used to amplify DOWNTAGs from 400 ng genomic DNA isolated from EtBr-treated cells, whereas Cy3-labeled primers were used to PCR amplify the DOWNTAGs of cells from the control culture. In a fourth experiment, the dyes were swapped. The PCR products were used as hybridization probes to oligonucleotide microarrays (a gift of D. Shoemaker and J. Boeke, Johns Hopkins University) containing the complementary DOWNTAG sequences from each YKO (in triplicate) as described (Shoemaker et al., 1996; Winzeler et al., 1999; Ooi et al., 2001; Giaever et al., 2002).

After hybridizations, microarray slides were scanned and analyzed as described (Lee and Spencer, 2004). Briefly, for each YKO, the mode pixel value for each spot was log2 transformed and quantile normalized (Bolstad et al., 2003). For each of four independent hybridization experiments (two hybridizations for each of two experimental replicates), a summary score for each YKO was calculated by taking the median value of the triplicate DOWNTAG spots present on each slide. From these summary scores from both the Cy5 and Cy3 channels, we determined a relative ratio of hybridization between the control probe (–EtBr) and experimental probe (+EtBr). Finally, the ratios from our four hybridizations were averaged to give the final ratio for each YKO (see Supplementary Table 3). YKOs with large ratios (high relative abundance in the control sample and low relative abundance in the sample treated with EtBr) were candidates for further testing. We note that for each hybridization, YKOs with triplicate signal variance that was greater among the control signals than between the control and experimental signals were not assigned ratio scores and dropped from the analysis.

Plasmid Constructions
pM486, a CEN6-LEU2 plasmid that expresses an Mgr1p-GFP fusion protein was constructed by PCR amplifying the MGR1 open reading frame (ORF) and 498 base pairs of upstream sequence yeast genomic DNA (Hoffman and Winston, 1987) using oligonucleotides 1274 and 1275. The PCR fragment was digested with XhoI and NotI and inserted into XhoI/NotI-digested pAA1, which encodes the green fluorescent protein (GFP; Sesaki and Jensen, 1999). The full-length Mgr1p-GFP fusion protein was functional, rescuing the petite-negative phenotype of mgr1 cells. pT175, which expresses Mgr1p from the SP6 promoter was generated by PCR amplification of the MGR1 ORF from genomic DNA using primers 1770 and 1771. After digestion with EcoRI and HindIII, the MGR1-containing PCR fragment was inserted into EcoRI/HindIII-cut pSP64 (Promega, Madison, WI). pRS315-ATP3 (pM487) and pRS315-ATP3-5 (pM488) were constructed by PCR amplifying the ATP3 gene from wild-type strain PTY44 (Thorsness and Fox, 1993) and ATP3-5 strain PTY100 (Weber et al., 1995) using primers 1780 and 1781, digesting the PCR products with XhoI and NotI, and then inserting the DNA fragment into XhoI/NotI-digested pRS315 (Sikorski and Hieter, 1989).

Mitochondrial Fractionation
Mitochondria were isolated from yeast cells as described (Daum et al., 1982), except that SEH buffer (250 mM sucrose, 1 mM EDTA, 20 mM HEPES-KOH, pH 7.4) with 1 mM phenylmethylsulfonyl fluoride (PMSF; Sigma) and a 1:1000 dilution of a protease inhibitor cocktail (P8340; Sigma) was used. Osmotic shock of mitochondria and protease treatment of mitochondria and mitoplasts were as described (Kerscher et al., 2000), except that 200 µg of mitochondria or mitoplasts at 0.2 mg/ml were used. The separation of outer membrane and inner membrane vesicles by sucrose step-gradients were as described (Pon et al., 1989). Treatment of mitochondria with alkali was as described (Kerscher et al., 2000), except that treated samples were centrifuged for 60 min at 100,000 x g.

Proteins were analyzed by SDS-PAGE. Western blots to Immobilon filters (Millipore, Billerica, MA) were performed using standard techniques (Current Protocols Online; http://www.mrw2.interscience.wiley.com/cponline). HA-tagged proteins were identified by incubation of filters with mouse ascites fluid prepared using 12CA5 cells (Niman et al., 1983); BABCO, Berkeley, CA), and myc-tagged proteins were visualized using mouse ascites fluid prepared using 9E10 cells (Evan et al., 1985); Covance, Denver, PA). Mitochondrial proteins were identified using antiserum to Tim23p (Emtage and Jensen, 1993), Mas2p (Jensen and Yaffe, 1988), Yme1p (Thorsness et al., 1993), Phb1p (Steglich et al., 1999), and Phb2p (Steglich et al., 1999). Immune complexes were visualized using HRP-conjugated secondary antibody (Amersham Biosciences, Piscataway, NJ) followed by chemiluminescence (West Pico; Pierce, Biotechnology, Rockford, IL). Western blots were imaged using a Versadoc Imaging System and Quantity One software (Bio-Rad, Hercules, CA).

Import into Isolated Mitochondria
[³⁵S]methionine-labeled mitochondrial precursor proteins were synthesized using the TNT SP6-Quick Coupled Transcription/Translation System (Promega, Fitchburg, WI) and added to 3–5% of total import reaction. pT58, which was used to produce su9-DHFR, consists of a fusion between amino acids 1–69 of Neurospora crassa mitochondrial ATPase subunit 9 and mouse DHFR (Pfanner et al., 1987), and pT176, which encodes a fusion of amino acids 1–161 of Yta10p to DHFR^MUT (Leonhard et al., 1999) have been described. Imports were performed in import buffer (0.6 M sorbitol, 50 mM HEPES-KOH, pH 7.4, 25 mM KCl, 10 mM MgCl₂, 2mMKPO₄, pH 7.4, 0.5 mM EDTA, 1 mg/ml BSA, 2 mM ATP, 2 mM NADH) containing an ATP regeneration system (100 µg/ml creatine kinase [Sigma], 5 mM creatine phosphate [Sigma]). Import reactions were stopped by incubation on ice and/or by the addition of proteinase K. For imports into mitochondria lacking inner membrane potential, NADH was replaced by 1 µM valinomycin (Sigma). After centrifugation, import reactions were analyzed by SDS-PAGE, and ³⁵S-labeled proteins were detected and quantitated by phosphorimaging using a Molecular Imager FX (Bio-Rad) and Quantity One software.

Analysis of the Mgr1p-containing Complex
Agarose beads coupled to HA or myc antibodies (Niman et al., 1983; Evan et al., 1985) were prepared using the Seize Immunoprecipitation Kit (Pierce Chemical, Rockford, IL) according to manufacturer's instructions. Immunoprecipitations from detergent-solubilized mitochondria were as described (Sesaki et al., 2003), except that 0.5 mg of mitochondria was solubilized for 10 min in 1 ml of 1% digitonin, 50 mM NaCl, 30 mM HEPES-KOH, pH 7.4, containing a 1:1000 dilution of protease inhibitor cocktail and 1 mM PMSF. After removal of insoluble material by centrifugation at 12,500 x g for 10 min, mitochondrial lysates were incubated with antibody-coupled beads at 4°C for 4 h with gentle agitation. Sample beads were washed three times with 0.1% digitonin, 50 mM NaCl, 30 mM HEPES-KOH, pH 7.4, containing protease inhibitors before beads were resuspended and boiled for 5 min in 2x SDS sample buffer (2% SDS, 20% glycerol, 10 µg/ml bromophenol blue, 200 mM Tris-HCl, pH 6.8) containing 0.6 M -mercaptoethanol.

For blue-native electrophoresis, 600 µg mitochondria was resuspended on ice in 96 µl of 50 mM NaCl, 5 mM 6-aminocaproic acid, 100 mM Bis Tris, pH 7.0, 1x 2 macroglobulin, with a 1:1000 dilution of protease inhibitor cocktail and 1 mM PMSF. Then, 24 µl of 10% digitonin was added, and mitochondria were solubilized for 15 min. After removal of insoluble material by centrifugation at 12,500 x g for 10 min, 100–200 µg of mitochondrial protein was loaded and run on polyacrylamide gradient gels and Western blotted as described (Schagger and von Jagow, 1991; Arnold et al., 1998; Kerscher et al., 2000).

Antiserum to Mitochondrial Proteins
Antiserum to OM45p and Tom70p were raised using bacterially expressed MBP fusion proteins. For MBP-OM45p, the OM45 ORF lacking the first 22 amino acids was PCR amplified with primers 774 and 775, digested with HindIII and PstI, and inserted into HindIII/PstI-cut pMAL-cR1 (New England Biolabs, Beverly, MA) to form pB63. For MBP-Tom70p, the TOM70 ORF lacking the first 37 amino acids was PCR amplified with primers 776 and 777, digested with PstI and HindIII, and inserted into HindIII/PstI-cut pMAL-cR1 to form pB64. MBP fusion proteins were expressed in bacteria according to manufacturer's instructions and purified by SDS-PAGE, and antiserum to the proteins was raised in rabbits (Covance).

Microscopy
Yeast cells were grown to midlog phase in S medium containing 2% galactose and then examined with a Zeiss Axioskop microscope (Thornwood, NY) with a 100x Plan-Neofluor objective. DIC and fluorescent images were captured with an Orca ER CCD camera (Hamamatsu, Bridgewater, NJ) using Open Lab software, version 3.1.4 (Improvision, Lexington, MA).

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
A Genomewide Screen for Petite-negative Yeast Mutants
To identify new genes required for yeast cell viability in the absence of mtDNA, we performed a microarray-based screen for mutants unable to live on medium containing EtBr. Wild-type cells grown on EtBr-containing medium rapidly lose their mtDNA but continue to grow by fermentation on glucose-containing YEPD medium (Slonimski et al., 1968; Goldring et al., 1970). In contrast, petite-negative mutants lose viability on YEPD medium containing EtBr (Chen and Clark-Walker, 2000). Our studies with known mtDNA-requiring mutants, such as tom70 (Dunn and Jensen, 2003) showed that these cells stopped dividing in YEPD + EtBr medium after 12–14 generations (C. Dunn, unpublished observations).

For our screen, we used a collection of haploid yeast knockouts (YKOs; Giaever et al., 2002) each disrupted in a different nonessential ORF by a kanMX4 cassette conferring G418 resistance (Wach et al., 1994). Because each YKO contains unique identifier sequences (20-mer "tags"), individual strains in a mutant pool can be detected by hybridization of PCR-amplified tags to oligonucleotide microarrays (Shoemaker et al., 1996; Winzeler et al., 1999; Giaever et al., 2002). This approach efficiently allows comparison of YKO representation after growth under experimental and control conditions. A pool of haploid YKOs in YEPD medium was split into two aliquots and grown with or without 25 µg/ml EtBr for 18 generations. Genomic DNA was isolated from the treated and untreated cells, and tags were amplified using either Cy3- or Cy5-labeled primers to distinguish control and experimental pools. The PCR products were cohybridized on glass slide arrays containing tag oligonucleotide features, and the control:experimental signal ratio was determined for each YKO. For a YKO with decreased representation after EtBr culture (due to lethality or slow growth), we expected that the control:experimental signal ratio would be higher in comparison to the majority of strains in the pool, which are much less affected by loss of mtDNA. Using this strategy, we identified candidate EtBr-sensitive mutants (Figure 1A). We have used these data to construct a table of YKOs, showing those most severely affected by EtBr at the top of the table (see Supplementary Table 3)

View larger version (31K): [in this window] [in a new window]   Figure 1. Yeast knockouts that require mtDNA for viability. (A) Distribution of YKOs after growth in EtBr-containing medium. In microarray analysis, the log2-converted ratio of the amount of hybridization to the probe from control cultures (–EtBr) and the probe from experimental cultures (+EtBr) for each YKO in our pool was determined. This ratio is plotted on the Y-axis. Thus, YKOs whose growth is most affected by EtBr are to the left, and those least affected are to the right. Strains above the dotted line were candidates for further testing. (B) Representative mutants from the genomewide screen. mgr1 (RJ2058), phb1 (RJ2083), opi1 (RJ2084), mgr2 (RJ2085), thr1 (RJ2086), thr4 (RJ2087), ira2 (RJ2088), pde2 (RJ2089), and yjr120w (RJ2091) cells were grown 7 h in YEPD broth at 30°C without ethidium bromide (–EtBr) or for 22 h in YEPD containing 25 µg/ml EtBr (+EtBr). A 4-µl aliquot of cells at OD600 of 0.02, and serial 10-fold dilutions thereof, were spotted onto YEPD (–EtBr) or YEPD + EtBr (+EtBr) plates and grown at 30°C for 2 d. As controls, wild-type strain BY4742 and two known petite-negative mutants, atp2 (RJ1577) and yme1 (RJ2051) were also examined. (C) Growth of mgr1 cells is defective in EtBr medium. WT (BY4742) and mgr1 (RJ2058) strains were inoculated into YEPD medium and then transferred to YEPD with 25 µg/ml EtBr. At indicated times, the OD600 of each culture was determined and the number of doublings was calculated.

To more fully characterize mtDNA-dependent YKOs, we took the 104 YKO strains that our microarray studies indicated were the most defective in their growth on EtBr-containing medium, and directly examined them for their ability to grow without mtDNA. We patched these 104 strains onto YEPD medium containing 25 µg/ml EtBr for 3 d at 30°C and then passaged them onto YEPD plates lacking EtBr at 30°C for another 3 d. Thirty-four mutants showed a strong growth defect after growth on EtBr (see Supplementary Table 3). The other YKOs showed a less severe or more variable growth defect after EtBr treatment and were not further analyzed. As an independent test for mtDNA-dependence, we crossed each of the 34 remaining YKOs to the mrpl16 mutant, which lacks a subunit of the mitochondrial ribosome (Pan and Mason, 1995) and is respiratory deficient. We reasoned that strains lacking the L16 subunit of mitochondrial ribosomes would be unable to translate mtDNA-encoded proteins and would therefore phenocopy a strain that has been forced to lose mtDNA by EtBr treatment. The 34 YKOs were crossed to mrpl16, sporulated and the viability of the spores containing both the YKO disruption and the mrpl16 mutation were examined. For 12 YKOs, the double mutants showed a strong synthetic lethal growth defect, and only microcolonies formed after spore germination. These strains are denoted in Supplementary Table 3 and include three mutants, tim18, tom70, and fmc1, which were previously described as petite-negative (Kerscher et al., 2000; Lefebvre-Legendre et al., 2001; Dunn and Jensen, 2003). Moreover, yjr120w was found in our screen (Figure 1B), and this mutation affects expression of ATP2, a gene known to be required by rho⁰ yeast (C. Dunn, unpublished results). We also found that cells lacking Phb1p, a component of the IM prohibitin complex, are petite-negative (Figure 1B). Cells lacking a functional prohibitin complex have previously been described as containing misshapen mitochondria after mtDNA loss (Berger and Yaffe, 1998), but phb1 has not been described as a petite-negative mutant. The petite-negative phenotype of phb1 is likely dependent upon strain background, because strains deleted of PHB1 in a different background [FY background; (Winston et al., 1995)] than that used in our screen remain viable after mtDNA loss (C. Dunn, unpublished observations). Seven other mutants were also not previously known to be mtDNA dependent (Figure 1B), including opi1, thr1, thr4, ira2, pde2, and uncharacterized mutants ycl044c and ypl098c. We refer to YCL044C as MGR1 (Mitochondrial Genome Required) and to YPL098C as MGR2. We focus our efforts below on MGR1.

MGR1 Is Required for the Normal Growth of Yeast Cells Lacking mtDNA
Like the known petite-negative mutants, atp2 (Chen and Clark-Walker, 1999) and yme1 (Thorsness et al., 1993), mgr1 cells cannot lose their mtDNA and fail to grow after treatment with EtBr (Figure 1B). When wild-type and mgr1 strains were transferred from YEPD medium lacking EtBr into medium containing 25 µg/ml EtBr, we found that the doubling times of wild-type and mgr1 strains were equivalent for 25–30 h (Figure 1C). After this time, wild-type cells continued to divide at a constant rate, whereas the mgr1 cells stopped dividing.

We noticed that at much later times (70 h) the mgr1 culture began to recover and attained a wild-type growth profile between 80 and 110 h. We postulated that this recovery might be due to the accumulation of bypass mutations. We isolated six viable mgr1 rho⁰ cells after culture in YEPD + EtBr and crossed them to wild-type cells. After meiotic analysis, we found that each of the six isolates contained a defect in a single nuclear-encoded gene. Two isolates carried recessive suppressors, and four isolates contained dominant suppressors (C. Dunn, unpublished results). We postulate that EtBr is stimulating the rapid accumulation of nuclear mutations in our mgr1 cultures. Supporting this view, we found a number of YKOs defective in nuclear DNA repair, such as RAD57, MUS81, MMS4, XRS2, RAD54, RAD59, MMS1, RAD55, and RAD53 (Supplementary Table 3), in our microarray screen. Because these repair mutants are not petite-negative, it is likely that EtBr mutagenizes nuclear DNA even at the concentrations used to remove functional mtDNA and thereby promotes the accumulation of mgr1 suppressors. Interestingly, we also found that the mgr1 petite-negative phenotype is variable according to genetic background; mgr1 was not required for viability of ⁰ cells derived from strain PTY44 (Supplementary Table 1; C. Dunn, unpublished observations).

Mgr1p Is a Mitochondrial IM Protein
MGR1 is predicted to encode a 47.1-kDa protein with two potential membrane-spanning segments. Mgr1p is homologous to proteins encoded by genes found in other yeasts, such as Kluyveromyces lactis (KLLA0C01089g; 39% identical by BLASTP), Eremothecium gossypii (AFR719W; 32% identical by BLASTP), and the pathogenic Candida glabrata (CAGL0B00682g; 38% identical by BLASTP). However, we could not find significant homology to nonfungal proteins. A recent proteomic analysis of yeast mitochondria suggested that Mgr1p is a mitochondrial protein (Sickmann et al., 2003). To confirm this localization, we fused the GFP to the carboxyl-terminus of Mgr1p and expressed this construct in mgr1 cells. Because Mgr1p-GFP rescued the growth defect of mgr1 cells grown in EtBr-containing medium, we concluded that the fusion protein is functional (C. Dunn, unpublished observations). When cells expressing Mgr1p-GFP were examined by fluorescence microscopy, we found that the fusion protein was localized to tubular organelles that also stained with the mitochondria-specific dye, Mitofluor 589 (Figure 2A). We conclude that Mgr1p is indeed a mitochondrial protein. Supporting this view, we found that Mgr1p could be imported into isolated mitochondria (Figure 2B). In vitro transcription and translation of MGR1 produced a 50-kDa protein. When the ³⁵S-labeled Mgr1 protein was added to energized mitochondria, Mgr1p was imported into the organelle and became resistant to exogenously added protease. When the mitochondrial IM potential was dissipated, however, Mgr1p was not imported and was mostly digested by the protease treatment. In contrast to the presequence-containing su9-DHFR fusion protein, we found the mobility of Mgr1p was not altered after import into mitochondria (Figure 2B). Thus, Mgr1p does not appear to contain a cleavable presequence.

View larger version (39K): [in this window] [in a new window]   Figure 2. Mgr1p is a mitochondrial IM protein with its carboxyl-terminus facing the IMS. (A) Mgr1p is a mitochondrial protein. mgr1 strain RJ1688 with plasmid pM486, which expresses the Mgr1p-GFP fusion protein, was stained with 2 µM Mitofluor 589 (Molecular Probes) and examined by fluorescence microscopy. Bar, 2 µm. (B) Mgr1p is imported into isolated mitochondria. 35S-labeled Mgr1p or su9-DHFR were mixed with mitochondria from wild-type strain RJ1962 with (+) or without (–) an inner membrane potential. Some samples (+PK) were digested after the import reaction with 100 µg/ml proteinase K on ice for 20 min. After centrifugation, samples were analyzed by SDS-PAGE and phosphorimaging. The precursor (p) and mature (m) forms of su9-DHFR and Mgr1p are indicated. (C) Mgr1p is an integral membrane protein. Mitochondria from strain RJ1970, which expresses Mgr1p-myc, were resuspended in breaking buffer (BB; 0.6 M sorbitol, 20 mM HEPES-KOH, pH 7.4) or in 0.1 M sodium carbonate, pH 11. After centrifugation, equal amounts of the supernatant (S) or pellet (P) fractions were analyzed by Western blotting using antibodies to the myc epitope (Mgr1p-myc), Tim23p, an integral membrane protein, or Mas2p, a soluble matrix marker. (D) Mgr1p is located in the mitochondrial IM. Mgr1p-myc mitochondria from strain RJ1970 were sonicated and membrane vesicles separated on sucrose step gradients. Fractions from the gradients were analyzed by Western blotting with antibodies to the myc epitope (Mgr1p-myc), the IM protein F1, or the OM protein, OM45. Fraction 1 represents the top of the gradient. (E) The carboxyl-terminus of Mgr1p-myc faces the IMS. Intact mitochondria from MGR1-MYC strain RJ1970, or mitochondria whose OM was disrupted by osmotic shock (+OS), were digested with 50 µg/ml PK for 30 min on ice and then analyzed by Western blotting using antibodies to the myc epitope (Mgr1p-myc), the matrix protein Mas2p, the OM protein Tom70p, or the IM protein Tim23p.

We found that the carboxyl-terminus of Mgr1p faces the IMS. When intact mitochondria containing Mgr1p-myc were treated with protease, Mgr1p-myc, along with the inner membrane Tim23 protein, and matrix-localized Mas2p were protected from digestion (Figure 2E). Only the outer membrane Tom70 protein was removed by the protease treatment. In contrast, when the mitochondrial outer membrane was disrupted by osmotic shock (OS) to form mitoplasts, the immunoreactive domain of Tim23p that faces the IMS (Ryan et al., 1998) and the carboxyl-terminal epitope of Mgr1p-myc were now digested. Only the matrix Mas2 protein was protected from the protease in osmotically shocked mitochondria. We note that no new, protease-protected Mgr1p-myc fragments were detected when mitoplasts were treated with protease. Because Mgr1p is predicted to contain two transmembrane segments, our results suggest that Mgr1p resides in the mitochondrial IM with both its amino- and carboxyl-termini facing the IMS.

Mgr1p Is a Subunit of the i-AAA Protease Complex
Our preliminary analysis using gel filtration of detergent-solubilized mitochondria indicated that Mgr1p exists in the IM within a structure of more than 600 kDa (C. Dunn, unpublished observations). Several protein complexes in the IM are important for yeast cell viability in the absence of mtDNA, and three of these complexes, the F₁F_O-ATP synthase, the i-AAA protease, and the prohibitin complex, are larger than 600 kDa (Leonhard et al., 1996; Arnold et al., 1998; Steglich et al., 1999). In coimmunoprecipitation studies, we found that Mgr1p is a new member of the i-AAA protease complex. The i-AAA complex has been shown to be 850 kDa in size, with only one known subunit, the 82-kDa Yme1 protein (Langer et al., 2001; Arnold and Langer, 2002). We isolated mitochondria from cells expressing Mgr1p-myc and solubilized the mitochondria in buffer containing 1% digitonin. We then immune-precipitated Mgr1p-myc using antibodies to the myc epitope and analyzed the pellet fractions by Western blotting. As shown in Figure 3A, our antibodies pelleted a significant amount of Mgr1p-myc from the mitochondrial lysate. We found that a similar amount of Yme1p coprecipitated with Mgr1p-myc, indicating that Yme1p is associated with the Mgr1 protein in mitochondria. Other IM proteins that are not part of the i-AAA complex, such as the -subunit of the F₁-ATPase or the two prohibitin complex members Phb1p and Phb2p, did not precipitate with Mgr1p-myc. To further investigate the interaction between Yme1p and Mgr1p, we inserted three tandem HA-epitopes (Niman et al., 1983; Longtine et al., 1998) at the carboxyl-terminus of Yme1p in a strain that also expressed Mgr1p-myc. Mitochondria from this strain were solubilized in digitonin buffer, and the Yme1p-HA fusion protein was immuneprecipitated. We found that Mgr1p-myc coimmunoprecipitated along with Yme1p-HA (Figure 3B), further suggesting a physical association between Mgr1p and Yme1p. We note that the Mgr1p-Yme1p interaction is not detergent specific, because Mgr1p and Yme1p also coprecipitated when mitochondria were solubilized with 2% Triton X-100 (C. Dunn, unpublished observations). Furthermore, even though the Yme1 protein is an ATP-dependent protease (Nakai et al., 1995; Leonhard et al., 1996; Weber et al., 1996), the presence or absence of ATP in our buffers made no difference in the Mgr1p-Yme1p interaction (C. Dunn, unpublished observations).

View larger version (40K): [in this window] [in a new window]   Figure 3. Mgr1p is a subunit of the i-AAA protease complex. (A) Yme1p coprecipitates with Mgr1p-myc. Mitochondria from MGR1-MYC strain RJ1970 were solubilized in buffer containing 1% digitonin, and the Mgr1p-myc protein was then precipitated using anti-myc antibodies coupled to agarose beads. Aliquots from the starting lysate (load) and the pellet fraction (IP) were analyzed by Western blotting with antibodies to the myc epitope (Mgr1p-myc), Phb1p, Phb2p, F1, and Yme1p. As a control, mitochondrial lysates from wild-type mitochondria (MGR1) were analyzed in parallel. (B) Mgr1p-myc coprecipitates with Yme1p-HA. Mitochondria isolated from strain RJ1980, expressing both Mgr1p-myc and Yme1p-HA fusion proteins, were solubilized in digitonin-containing buffer, and the Yme1p-HA protein precipitated with agarose beads linked to anti-HA antibodies. As a control, mitochondria from YME1 MGR1-MYC strain RJ1970 were also analyzed. Aliquots from the mitochondrial lysate (load) and precipitated proteins (IP) were Western blotted using anti-HA (Yme1p-HA) or anti-myc (Mgr1p-myc) antibodies.

Also suggesting that Mgr1p is part of the Yme1p-containing i-AAA complex, we found that Mgr1p comigrates with Yme1p during blue-native PAGE (BN-PAGE). In these studies, mitochondria containing both Mgr1p-myc and Yme1p-HA were solubilized with digitonin-containing buffer, and membrane complexes were separated on nondenaturing gels. Western blots of our blue-native gels indicated that the majority of Yme1p-HA migrated in a large complex of 800 kDa (Figure 4A, open arrow), consistent with its previously reported size (Leonhard et al., 1996). Surprisingly, we also found a significant amount of Yme1p-HA in a slightly smaller complex (Figure 4A, black arrow). We found that the bulk of Mgr1p-myc comigrated with the larger form of the Yme1p-containing complex, with a lesser amount of Mgr1p-myc migrating as several smaller species, possibly representing other Mgr1p complexes. We also note that when we attempted to separate Mgr1p-myc, Yme1p, and Yme1p-HA complexes using BN-PAGE, some protein did not enter our resolving gels (Figure 4, A–C, asterisks) and therefore may exist in very large complexes that we cannot resolve using this technique.

View larger version (43K): [in this window] [in a new window]   Figure 4. The i-AAA protease complex requires both Mgr1p and Yme1p. (A) Mgr1p comigrates with Yme1p during blue-native gel electrophoresis. Mitochondria isolated from strain RJ1980 were solubilized in digitonin-containing buffer, and protein complexes were separated on a 3–13% polyacrylamide blue-native gel. Western blotting was used to locate the (1) Yme1p-HA and (2) Mgr1p-myc proteins. The open and black arrows denote two apparent forms of the i-AAA complex. (B) The size of the Yme1p-containing complex decreases in the absence of Mgr1p. Mitochondria were isolated from WT (RJ1962), mgr1 (RJ1961), and phb1 (RJ2083) cells and then solubilized in digitonin buffer. Protein complexes were separated on a 3–8% polyacrylamide blue-native gel and analyzed by Western blotting with anti-Yme1p antibodies. The open and black arrows denote two apparent forms of the i-AAA complex. (C) The mobility of the main Mgr1p-containing complex changes in mitochondria lacking Yme1p. Mitochondria isolated from wild-type cells expressing Mgr1p-myc (RJ1970), or yme1 cells expressing Mgr1p-myc (RJ1972) were solubilized, run on a 3–13% polyacrylamide blue-native gel and analyzed by Western blotting with anti-myc antibodies. The arrows denote the two main forms of the Mgr1p-containing complex. In A, B, and C, Yme1p, Yme1p-HA, or Mgr1p-myc that has not entered the resolving gel is labeled with an asterisk.

Mitochondria Lacking Mgr1p Are Defective in Protein Turnover
The i-AAA protease complex has been shown to mediate turnover of a number of IM proteins (Nakai et al., 1995; Pearce and Sherman, 1995; Weber et al., 1996; Lemaire et al., 2000; Leonhard et al., 2000; Kominsky et al., 2002; Augustin et al., 2005). One such substrate is Nde1p, subunit 1 of a mitochondrial NADH dehydrogenase complex that has a catalytic domain located in the IMS (Luttik et al., 1998). Fusion of the HA epitope to the carboxyl-terminus of Nde1p creates an unstable protein whose turnover is deficient in yme1 mitochondria (Augustin et al., 2005). To examine the role of Mgr1p in protein turnover, we generated wild-type, mgr1, and yme1 strains, each expressing the Nde1p-HA construct. We added cycloheximide to cultures of these three strains to stop protein synthesis and then examined the Nde1p-HA levels at different times after the translation arrest. In wild-type cells, Nde1p-HA disappeared with a half-life of 15 min (Figure 5A). Consistent with previous results (Augustin et al., 2005), we found that Nde1p-HA was much more stable in yme1 cells. No turnover of Nde1p-HA was seen in the 75 min of our study. Although the proteolysis defect of mgr1 cells was not as dramatic as that of yme1 cells, we found that degradation of Nde1p-HA was significantly reduced when Mgr1p was absent. We estimated that the initial half-life of Nde1p-HA in mgr1 cells is 23 min, a 50% increase compared with wild-type cells. We noted that the Nde1p-HA turnover defect in mgr1 and yme1 cells was also apparent before cycloheximide treatment. Steady state levels of Nde1p-HA were 4-fold higher in yme1 cells and 1.5-fold higher in mgr1 cells than in wild-type cells (Figure 5A, see 0-min time points).

View larger version (22K): [in this window] [in a new window]   Figure 5. Mitochondria lacking Mgr1p are defective in turnover of IM proteins. (A) The Nde1p-HA fusion protein is more stable in mgr1 and yme1 cells. Wild-type strain RJ2077 (diamonds), mgr1 strain RJ2078 (squares), and yme1 strain RJ2079 (triangles) each expressing Nde1p-HA were grown to midlog phase at 30°C in YEP glycerol/ethanol medium. Cycloheximide was then added to 1 mg/ml and the cultures were shifted to 37°C. At the indicated times, cells were lysed, equal amounts of cellular protein were loaded in each lane, and the amount of Nde1p-HA was determined by Western blotting using antibodies to the HA-epitope (n = 3). (B) Turnover of the Yta10(161)-DHFRMUT fusion protein is reduced in mgr1 and yme1 mitochondria. The 35S-labeled Yta10(161)-DHFRMUT precursor was imported at 25°C for 10 min into mitochondria isolated from WT strain RJ1962 (diamonds), mgr1 strain RJ1961 (squares), and yme1 strain RJ1974 (triangles). Precursor not imported was digested with 100 µg/ml proteinase K on ice for 30 min. After the addition of 1 mM PMSF, samples were shifted to 25°C and incubated for the indicated times. Equal amounts of mitochondria were isolated by centrifugation at each time point, subjected to SDS-PAGE, and analyzed by phosphorimaging (n = 3). The processed forms of Yta10(161)-DHFRMUT (asterisk) were quantified.

View larger version (51K): [in this window] [in a new window]   Figure 6. Several phenotypes of the yme1 mutant are not found in mgr1 cells. (A) Lack of Mgr1p does not increase mtDNA escape to the nucleus. trp1 strain PTY44, trp1 mgr1 strain RJ2001, and trp1 yme1 strain RJ2040, each containing the nuclear TRP1 marker in their mitochondria, were grown on YEP glycerol/ethanol medium for 4 d at 30°C. Strains were then replica-plated to SD medium lacking tryptophan and grown for a further 4 d at 30°C. (B) mgr1 mutants are not heat-sensitive for growth. WT (PTY44), mgr1 (RJ2001), and yme1 (RJ2040) strains were struck to YEP glycerol/ethanol medium and incubated at 37°C for 5 d. (C) mgr1 cells are not cold-sensitive. WT (BY4742), mgr1 (RJ2059), and yme1 (RJ2051) strains were struck to YEPD medium and incubated for 6 d at 18°C.

mgr1 Mutants Show Less Severe Phenotypes than yme1 Cells

Generation of Yeast Cells Lacking Both the m-AAA and i-AAA Protease Complexes
The mitochondrial IM contains two AAA protease complexes, the i-AAA protease, whose catalytic domain faces the IMS, and the m-AAA protease, which faces the matrix (Langer et al., 2001; Arnold and Langer, 2002). Previous studies suggest that the two assemblies might overlap in their substrate selection (Leonhard et al., 2000) and work together to degrade one or more mitochondrial proteins. Consistent with this idea, yeast mutants deficient in either the i-AAA or the m-AAA protease complex are viable, but double mutants lacking both complexes are dead (Lemaire et al., 2000; Leonhard et al., 2000). However, the petite-negative phenotype of the yme1 mutant suggests an alternative explanation for the lethality of cells lacking both i-AAA and m-AAA protease complexes. yta10 and yta12 cells, which lack m-AAA activity, behave like petite mutants—they grow very poorly on nonfermentable medium (Guelin et al., 1994; Tauer et al., 1994; Tzagoloff et al., 1994). This petite phenotype of yta10 and yta12 mutants is thought to result from defects in the assembly of inner membrane protein complexes (Tzagoloff et al., 1994; Paul and Tzagoloff, 1995). We postulated that the petite phenotype of yta10 and yta12 mutants could be incompatible with the petite-negative yme1 mutant. To test this idea, we constructed a diploid strain heterozygous for disruptions in YTA10, YTA12, and YME1. To suppress the petite-negative defect of the yme1 mutant (but not the i-AAA-dependent proteolysis defect), we transformed the diploid with a plasmid carrying the ATP3-5 allele. ATP3-5 encodes a mutant version of the -subunit of the F₁-ATPase and allows yme1 cells to grow without mtDNA (Weber et al., 1995). As a control, a plasmid encoding the wild-type ATP3 allele was also used. After sporulation, 16 tetrads from each diploid were dissected onto YEPD medium and incubated for 5 d. As expected, diploids transformed with the wild-type ATP3 gene yielded no viable colonies composed of yme1 yta10, yme1 yta12, or yme1 yta10 yta12 cells. In contrast, 7 yme1 yta10 or yme1 yta12 double mutants, and six triple mutants were isolated from diploids carrying the ATP3-5 plasmid. Our results thus indicate that yeast cells lacking both m-AAA and i-AAA protease activity can be constructed, and that the synthetic lethality of yme1 yta10 and yme1 yta12 double mutants is due to the petite-negative property of the yme1 mutant and perhaps not due simply to overlapping substrate selection of the i-AAA and m-AAA proteases. We speculate that other examples of synthetic lethality, such as for mutants lacking both the prohibitin complex and genes required for mitochondrial shape (Berger and Yaffe, 1998), or for mutants lacking both m-AAA protease and prohibitin function (Steglich et al., 1999), might instead be due to the intolerable combination of a mutation that confers mtDNA-dependence, such as phb1 (see Figure 1), with a mutation that causes cells to either lose their mtDNA or to lose the ability to properly assemble mtDNA-encoded proteins into functional complexes. Regardless, we have shown that viable yeast cells lacking both i-AAA and m-AAA activities can be constructed.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
In contrast to many eukaryotic organisms, S. cerevisiae is able to grow in the absence of mtDNA. In an attempt to better understand the molecular basis for this survival, we conducted a large-scale hunt for yeast mutants that are dependent on their mtDNA for cell viability. Using a microarray-based approach, we searched among viable YKOs for those unable to grow when mtDNA loss was induced by growth on EtBr-containing medium. Although we have identified several new genes, it is clear that our screen was not exhaustive. Our microarray analysis yielded some previously known mutants, such as fmc1, which are defective in assembly of the F₁ sector of the mitochondrial F₁F_O-ATP synthase (Lefebvre-Legendre et al., 2001), and tim18 and tom70 (Kerscher et al., 2000; Dunn and Jensen, 2003), which are defective in protein import. Other known petite-negative mutants were not found. These include mutants lacking subunits of the F₁-ATPase, atp1, atp2, and atp3, and the yme1 mutant, defective in the i-AAA protease complex. We know that many strains were missing from the pool of YKOs that we screened. Only 3800 out of the total 4900 viable YKOs were detected in the final pools. This is likely a byproduct of the progressive loss of slow growing mutants during the 18 generations of outgrowth. Moreover, some of YKO strains contain tag sequence mutations preventing proper hybridization of the probe to the microarray (Eason et al., 2004). Although there may be additional genes to be identified through modifications of procedure, this study adds many interesting new proteins to the inventory.

Among the mutants that we identified in our screen for yeast knockouts that cannot live without mtDNA was a strain disrupted in an uncharacterized ORF (YCL044C), encoding a protein that we have named Mgr1p. We found that Mgr1p, like the Yme1 protein, is a subunit of the i-AAA protease complex in the mitochondrial IM. We also find that mgr1 mutants, like yme1 cells, are defective in the turnover of IM proteins. However, because the Mgr1 protein contains no conserved protease motifs, we speculate that Mgr1p regulates the import, assembly or activity of the catalytic subunit, Yme1p. Suggesting a role in assembly, we found that in wild-type cells Yme1p is located in two large IM complexes with masses of 700 and 800 kDa, but in mgr1 cells, the Yme1 protein is shifted to the smaller, 700-kDa form. Alternatively, the Mgr1 protein may function like Escherichia coli SspB, which delivers substrates to the ClpXP complex, a bacterial member of the AAA protease family (Levchenko et al., 2000). Because the most conserved region of Mgr1p (amino acids 37–53) is localized to the IMS, the Mgr1 protein is poised to present unfolded or unassembled IM proteins to the IMS-facing protease domain of Yme1p (Leonhard et al., 1996).

Why are the yme1 and mgr1 mutants dependent on mtDNA for viability? In rho⁰ cells, both the electron transport chain and the F_O portion of the ATP synthase are not functional because of the lack of several mtDNA-encoded subunits (Tzagoloff, 1982). Therefore, the essential mitochondrial potential can be generated by neither electron transport chain activity nor reversal of the ATP synthase (i.e., turning the ATPase into a proton pump). However, the F₁ part of the ATP synthase remains active in petite cells and appears critical in generating the IM potential (Ebner and Schatz, 1973; Giraud and Velours, 1997; Chen and Clark-Walker, 1999). ATP made by glycolysis in the cytosol is transported into mitochondria via the inner membrane ATP/ADP carrier proteins in exchange for the ADP produced by the matrix-localized F₁-ATPase. The i-AAA protease is proposed to play an important role in regulating F₁-ATPase activity in petite cells. For example, mitochondria isolated from yme1 cells depleted of mtDNA contain reduced F₁-ATPase activity and are deficient in generating with added ATP (Kominsky et al., 2002). Moreover, the need for Yme1p can be bypassed by specific mutations in F₁-ATPase subunits (Weber et al., 1995). One hypothesis for the requirement for i-AAA protease activity in petite cells is that the Yme1p-containing complex degrades an inhibitor of the F₁-ATPase. Supporting this idea, deletion of the F₁-ATPase inhibitor, Inh1p, bypasses the need for Yme1p in petite cells (Kominsky et al., 2002). However, because the Inh1 protein is located in the matrix and the catalytic domain of i-AAA is in the IMS, it is unlikely that Inh1p is a direct target of the i-AAA protease.

An alternative explanation for the mtDNA-dependence of yme1 and mgr1 mutants is that the i-AAA protease is needed to degrade the unassembled, nuclear-encoded subunits of the oxidative phosphorylation machinery that accumulate in the absence of the mtDNA-encoded subunits. Supporting a requirement for robust IM quality control in rho⁰ cells, we found that the phb1 mutant, deficient in a putative IM chaperone (Nijtmans et al., 2000), is petite-negative. Accumulation and possible aggregation of misassembled proteins in mgr1, yme1, and phb1 mutants could lead to "leaks" in the IM and overwhelm the ability of the F₁-ATPase to maintain in rho⁰ mitochondria. In this model, the suppression of petite-negative phenotype of the yme1 mutant by disrupting INH1 can be explained by the observation that F₁-ATPase inhibitors like Inh1p are more potent when the IM potential is decreased (Ichikawa et al., 1990; Walker, 1994). Further studies are clearly needed to clarify the requirement for the i-AAA protease in cells lacking mtDNA.

In addition to a new i-AAA complex member, our screen also identified YKOs lacking known proteins with no previous connection to mtDNA dependence. These proteins, which include Thr1p, Thr4p, Ira2p, Pde2p, and Opi1p, play roles in a surprising number of different cellular processes. Thr1p and Thr4p are involved in threonine biosynthesis (Mannhaupt et al., 1990; Ramos and Calderon, 1994). Ira2p, a Ras-GAP protein (Tanaka et al., 1990), and Pde2p, a cyclical AMP phosphodiesterase (Sass et al., 1986), are components of the protein kinase A (PKA) signal transduction pathway. Opi1p is a regulatory protein, repressing the transcription of phospholipid biosynthetic enzymes (Greenberg et al., 1982). Although it is unexpected that these proteins were identified in our screen, some of them have clear links to mitochondrial function. For example, several mutants auxotrophic for threonine were previously found to be deficient in cytochrome oxidase activity (Robichon-Szulmajster et al., 1969; Surdin et al., 1969), and the PKA pathway controls the expression of at least one mitochondri